Trial Profile
Muscle Strength and -Mass After Bariatric Surgery - a Possible Effect of Testosterone Replacement Therapy? Randomized, Placebo-controlled and Double-blinded Study
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 21 Jan 2024
Price :
$35
*
At a glance
- Drugs Testosterone undecanoate (Primary)
- Indications Hypogonadism
- Focus Therapeutic Use
- 15 Jan 2024 Status changed from recruiting to active, no longer recruiting.
- 08 Jan 2024 Planned End Date changed from 1 Nov 2024 to 1 Jan 2025.
- 08 Jan 2024 Planned primary completion date changed from 1 Nov 2024 to 1 Jan 2025.